Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Acquisition

11 Nov 2014 07:00

RNS Number : 6552W
Tarsus Group PLC
11 November 2014
 

11 November 2014

 

Tarsus Group plc

 

Acquisition of the South Beach Symposium

 

Tarsus Group plc (LSE: TRS, "Tarsus" or the "Group"), the international business-to-business media group, has agreed to acquire 100% of the assets of the South Beach Symposium ("SBS") from SBS Medical Education LLC. SBS is a leading educational event for Dermatologists, Plastic Surgeons and other physicians and represents a significant addition to the Group's medical division.

 

The preventative medicine market in the US comprises four key pillars: neurological disorders, endocrinology, cardiovascular and cancer. Skin health is one of the most important elements of preventative medicine with skin cancers now accounting for nearly half of all cancers diagnosed in the United States. SBS' comprehensive approach to skin health education addresses the key areas of dermatology continuing medical education: medical, surgical, including cutaneous oncology, pediatric and aesthetics. Following Tarsus' acquisition earlier this year of a cardiovascular-focused event, the Cardiometabolic Health Congress ("CMHC"), the acquisition of SBS provides the Group with increased access to another key pillar of the US preventative medicine market.

 

In early 2014 the Group broadened its medical education offering with the launch of the Metabolic Medical Institute (MMI). This launch supports the Group's Quickening the Pace strategy which is focused on driving organic growth and making selective strategic acquisitions with a view to accelerating the growth of returns to shareholders. Along with CMHC, the acquisition of SBS accelerates the growth of MMI into the mainstream medical market.

 

Acquisition highlights

 

· Acquisition of 100% of the assets of SBS for a total cash consideration of US$6.4 million (the "Acquisition") with US$5.5 million payable on completion and deferred payments made to be made through to 2018 of US$0.9 million. The consideration will be met from existing financial resources.

· The Acquisition includes the immediate purchase of SBS's planned online education business "Dermatology Education Online" which will take both the existing medical education content of the event as well as new educational and promotional material and make it available to a wider audience online. Consideration for the online education business is payable in 2018 with reference to the profits of that business in 2017. The maximum consideration for the SBS online education business has been set at US$20 million.

· SBS takes place annually in Miami and the next edition will be held in February 2015.

· Founder Mark Nestor, M.D., Ph.D. will continue to lead SBS after its acquisition and is contracted through to the 2017 event.

· For the year ended 31 December 2013, the assets subject to the transaction recorded unaudited profit before tax of approximately US$0.8 million.

· The Acquisition is expected to be earnings accretive in the financial year ending 31 December 2015 and thereafter.

 

 

Douglas Emslie, Tarsus Group Managing Director, said:

 

"The acquisition of SBS is another key step in the transitioning of the Group's medical business and the implementation of the "Quickening the Pace" strategy. As we focus on taking preventative medicine into the mainstream medical market, the acquisition of SBS compliments the launch of MMI and the earlier acquisition of CMHC. These initiatives will accelerate our progress and provide a strong platform for growth".

 

Tarsus is hosting a Capital Markets Seminar for analysts and investors later today to be held at Skinners Hall, 8 1/2 Dowgate Hill, London EC4R 2SP at 4pm. The event will provide information on the Group's Medical division with an overview of the market and the Group's divisional strategy. No new material information will be made available.

 

For further information:

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director

+44 (0)20 8846 2700

Dan O'Brien, Group Finance Director

IR Focus

Neville Harris, Investor Relations

+44 (0)79 0997 6044

 

Notes to editors

 

Tarsus Group plc (LSE:TRS) is an international business-to-business media group with interests in exhibitions, publishing and online media. The Group operates globally in key verticals including aviation, medical, labels and packaging, discount clothing (Off-Price), housewares and automotive. Tarsus runs more than 80 events and websites and its flagship brands include the Labelexpo exhibitions in Europe, the Americas and Asia and the Dubai Airshow.

 

The Group operates across a worldwide network of offices in Dublin, London, Paris, Milwaukee, Boca Raton (Florida), Dubai, Shanghai, Jakarta, New Delhi and Istanbul. Tarsus is building on its strong presence in the emerging markets of the Middle East, China, Turkey, Indonesia and Mexico.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQVBLFFZFFZFBB
Date   Source Headline
26th Oct 20157:00 amRNSTrading Statement
21st Oct 20153:40 pmRNSHolding(s) in Company
1st Oct 20153:12 pmRNSTotal Voting Rights
3rd Sep 20151:56 pmRNSCompletion of disposal of French Business
1st Sep 20153:12 pmRNSResult of General Meeting
21st Aug 20153:50 pmRNSHalf Yearly Report
5th Aug 20152:17 pmRNSDirector/PDMR Shareholding
3rd Aug 201512:59 pmRNSPosting of Circular
3rd Aug 201510:03 amRNSTotal Voting Rights
31st Jul 20153:32 pmRNSTotal Voting Rights
29th Jul 20153:16 pmRNSDirector/PDMR Shareholding
29th Jul 20157:00 amRNSInterim results for six months
17th Jul 20157:00 amRNSAdditional Listing
13th Jul 20157:00 amRNSDisposal
6th Jul 20157:00 amRNSAcquisition
1st Jul 20153:38 pmRNSTotal Voting Rights
23rd Jun 20156:13 pmRNSResult of AGM
4th Jun 20154:09 pmRNSScrip Dividend Circular
22nd May 20153:29 pmRNSDirector/PDMR Shareholding
22nd May 20157:00 amRNSTrading Statement
18th May 20152:05 pmRNSNotice of AGM
8th May 20154:45 pmRNSBlock Listing Six Monthly Return
5th May 20154:39 pmRNSDirector/PDMR Shareholding
1st May 20153:04 pmRNSTotal Voting Rights
10th Apr 20153:58 pmRNS2014 Annual Report
31st Mar 20153:48 pmRNSTotal Voting Rights
17th Mar 20151:40 pmRNSDirector/PDMR Shareholding
9th Mar 20154:49 pmRNSDirector/PDMR Shareholding
4th Mar 20159:43 amRNSHolding(s) in Company
4th Mar 20157:00 amRNSFinal Results
2nd Mar 201512:07 pmRNSTotal Voting Rights
24th Feb 201512:42 pmRNSNotice of Full Year Results - 4 March 2015
30th Jan 20153:43 pmRNSTotal Voting Rights
20th Jan 20157:00 amRNSAdditional Listing
9th Jan 20157:00 amRNSBoard Changes
9th Jan 20157:00 amRNSYear-end trading update
18th Dec 20143:21 pmRNSScrip Dividend Circular
21st Nov 20142:52 pmRNSDirector/PDMR Shareholding
11th Nov 20147:00 amRNSAcquisition
11th Nov 20147:00 amRNSInterim Management Statement
10th Nov 20145:15 pmRNSBlocklisting Interim Review
6th Nov 20145:13 pmRNSHolding(s) in Company
30th Sep 20143:35 pmRNSTotal Voting Rights
17th Sep 20143:03 pmRNSDirector/PDMR Shareholding
1st Sep 20146:08 pmRNSInterim Financial Report
1st Sep 20146:03 pmRNSTotal Voting Rights
15th Aug 20148:56 amRNSDirector/PDMR Shareholding
13th Aug 20144:33 pmRNSDirector/PDMR Shareholding
12th Aug 20145:12 pmRNSDirector/PDMR Shareholding
31st Jul 20145:18 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.